Sign In

10.1 : Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of the action potential. Cardiac muscle cells exhibit unique electrical properties such as automaticity, excitability, and conductivity. These properties enable the cells to generate and propagate electrical impulses, ensuring a stable and coordinated heartbeat. The SA node in the right atrium serves as the primary pacemaker, initiating the electrical impulse responsible for each cardiac cycle. This impulse propagates through the specialized conducting system, which includes the atrioventricular (AV) node, the bundle of His, and Purkinje fibers, ensuring a rapid and orderly spread of excitation throughout the heart.

The action potential in cardiac cells comprises several phases (0-4), each characterized by specific ionic mechanisms. Phase 0 involves rapid depolarization due to the opening of voltage-gated sodium (Na+) channels, whereas phase 1 represents initial repolarization resulting from the transient outward potassium (K+) current. In phase 2, the plateau phase, calcium (Ca2+) influx through L-type Ca2+ channels balances the outward K+ current, maintaining the membrane potential. Phase 3 represents rapid repolarization due to increased K+ efflux, and phase 4 is the resting membrane potential maintained by the Na+-K+ pump and background ion channels. Various factors, including heart disease, drugs, and circulating hormones, can disrupt sinus rhythm. Heart diseases, such as ischemia or myocardial infarction, can impair the electrical conduction system. At the same time, certain drugs and hormones can modulate ion channel function, altering the action potential's trajectory and duration. In conclusion, the heart's electrophysiology involves a complex interplay of specialized structures, ion movements, and membrane potentials. These elements work cohesively to generate and maintain the normal cardiac rhythm, ensuring the efficient circulation of blood throughout the body.

Tags
ElectrophysiologyNormal Cardiac RhythmElectrical ActivitySinoatrial NodePacemaker FunctionAction PotentialCardiac Muscle CellsAutomaticityExcitabilityConductivityConducting SystemAtrioventricular NodeBundle Of HisPurkinje FibersIon ChannelsDepolarizationRepolarizationHeart Disease

From Chapter 10:

article

Now Playing

10.1 : Electrophysiology of Normal Cardiac Rhythm

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

293 Views

article

10.2 : Mechanism of Cardiac Arrhythmias

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

255 Views

article

10.3 : Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

262 Views

article

10.4 : Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

145 Views

article

10.5 : Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

223 Views

article

10.6 : Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

131 Views

article

10.7 : Pathophysiology of Cardiac Performance

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

215 Views

article

10.8 : Pathophysiology of Heart Failure

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

476 Views

article

10.9 : Heart Failure Drugs: Inotropic Agents

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

170 Views

article

10.10 : Heart Failure Drugs: Diuretics

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

119 Views

article

10.11 : Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

122 Views

article

10.12 : Heart Failure Drugs: β-Blockers

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

82 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved